Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, April 9, 2019

Applying New Guidelines, Imaging, and Insights on Extending the Treatment Window in Acute Ischemic Stroke

Maybe you want to have your hospital require this training. Although you will notice this is still just guidelines NOT PROTOCOLS. Survivors will need to be in charge of stroke before we ever get protocols and 100% recovery.  Whatever stroke leadership there is is obviously lazy and just waiting for SOMEONE ELSE TO SOLVE THE PROBLEMS IN STROKE!

 

Applying New Guidelines, Imaging, and Insights on Extending the Treatment Window in Acute Ischemic Stroke

The 2018 AHA/ASA Guidelines for the Early Management of Patients With Acute Ischemic Stroke include which of the following new recommendations?

  • When several intravenous (IV) alteplase-capable hospital options exist within a defined geographic region, the benefit of bypassing the closest to bring the patient to one that offers a higher level of stroke care is certain.
  • Tenecteplase 0.4-mg/kg single IV bolus is superior to alteplase and can be considered in patients with major neurological impairment and intracranial occlusion.
  • For patients with acute ischemic stroke (AIS), administration of IV alteplase, guided by telestroke consultation, may be as safe and beneficial as that of stroke centers.
  • For otherwise eligible patients with mild stroke presenting in the 4.5- to 6-hour window, treatment with IV alteplase may be reasonable.

No comments:

Post a Comment